Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health
Aug 1, 2020
Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people
The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
WORLD / Science & Health
Jul 30, 2020
Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12
The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Japan Times
WORLD / Science & Health
Jul 26, 2020
The supply chain to save the world is unprepared for a vaccine
The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the epic challenges of shipping an eventual COVID-19 vaccine from drugmakers to billions of people.
Japan Times
COMMENTARY / World
Jul 26, 2020
Britain's response to COVID-19 has been world class
One country has done more than any other to stop the spread of the coronavirus.
Japan Times
JAPAN / Science & Health
Jul 22, 2020
Japan approves dexamethasone as second drug for coronavirus treatment
The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.
Japan Times
WORLD / Science & Health
Jul 21, 2020
Wave of promising study results raise hopes for coronavirus vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects.
Japan Times
JAPAN / Science & Health
Jul 18, 2020
Fujifilm to start another Avigan study in Kuwait following setback in Japan
The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.
Japan Times
BUSINESS / Companies
Jul 17, 2020
Japan in talks with Johnson & Johnson to secure COVID-19 vaccine
The company has already agreed to prioritize an allocation to the United States as part of a funding agreement, according to the firm's chief financial officer.
Japan Times
WORLD / FOCUS
Jul 17, 2020
Coronavirus cold war flares up with claims of Russian vaccine hack
The international race for protection from the virus escalated to a new level with allegations that vaccine development has become a target of Russian cyberattacks.
Japan Times
JAPAN
Jul 17, 2020
Japan and Germany agree to cooperate over COVID-19 vaccine development
Abe told Merkel that his country will contribute to the development and distribution of vaccines through the WHO's ACT-Accelerator.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
Japan Times
JAPAN / Science & Health
Jul 10, 2020
Avigan's effectiveness inconclusive in Japan COVID-19 trial
Promoted heavily by Prime Minister Shinzo Abe, the flu drug did not yield any statistically significant results after administered to 89 patients across Japan.
Japan Times
COMMENTARY / World
Jul 8, 2020
The fight over a coronavirus vaccine will get ugly
Once COVID-19 shots become available, there will be arguments about who gets them, and an even bigger battle with anti-vaxxers who refuse them.
Japan Times
WORLD / Science & Health
Jul 7, 2020
Moderna spars with U.S. scientists over COVID-19 vaccine trials
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc., one of the leading developers, it has been learned.
Japan Times
BUSINESS / Companies
Jul 6, 2020
Takeda considers sale of OTC drug unit to focus on profitable products
Takeda Pharmaceutical Co. is considering selling its over-the-counter medicine unit for around ¥400 billion ($3.7 billion) to focus on developing cancer treatments and other advanced medical-use drugs that can generate higher profitability, a source said Monday.
Japan Times
BUSINESS
Jul 3, 2020
How Moderna execs are cashing in during the race to develop COVID-19 vaccine
Biotech firm Moderna Inc. could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
Japan Times
ASIA PACIFIC / Science & Health
Jul 2, 2020
How China's CanSino Biologics jumped to the front of the coronavirus vaccine race
The firm has boosted its scientific prowess by tying up with the Canadian government's largest research organization, maintaining links despite geopolitical rows.
Japan Times
JAPAN / Science & Health
Jul 1, 2020
Eisai to start clinical trial of experimental drug for COVID-19
Japanese pharmaceutical firm Eisai Co. is set to start clinical trials in the United States of its experimental drug eritoran in the battle against coronavirus, with results potentially available by the year-end, the company said Wednesday.

Longform

Things may look perfect to the outside world, but today's mom is fine with some imperfection at home.
How 'Reiwa moms' are reshaping motherhood in Japan